British Columbia Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8M Sell
170,998
-49,181
-22% -$6.89M 0.14% 123
2025
Q4
$27M Buy
220,179
+41,194
+23% +$5.01M 0.14% 140
2025
Q3
$19.9M Sell
178,985
-17,164
-9% -$1.95M 0.11% 161
2025
Q2
$21.7M Sell
196,149
-42,189
-18% -$4.49M 0.13% 147
2025
Q1
$26.7M Sell
238,338
-66
-0% -$6.81K 0.16% 129
2024
Q4
$22M Buy
238,404
+30,529
+15% +$2.75M 0.13% 152
2024
Q3
$17.4M Sell
207,875
-30,995
-13% -$2.37M 0.1% 162
2024
Q2
$16.4M Buy
238,870
+89,632
+60% +$5.98M 0.1% 169
2024
Q1
$10.9M Buy
149,238
+5,809
+4% +$447K 0.08% 184
2023
Q4
$11.6M Buy
143,429
+30,021
+26% +$2.34M 0.09% 163
2023
Q3
$8.5M Buy
113,408
+565
+0.5% +$43.5K 0.08% 180
2023
Q2
$8.7M Buy
112,843
+909
+0.8% +$72.5K 0.08% 185
2023
Q1
$9.29M Buy
111,934
+712
+0.6% +$59K 0.1% 182
2022
Q4
$9.55M Sell
111,222
-12,878
-10% -$1.02M 0.1% 174
2022
Q3
$7.66M Sell
124,100
-21,405
-15% -$1.35M 0.09% 193
2022
Q2
$8.99M Sell
145,505
-48,150
-25% -$2.98M 0.09% 203
2022
Q1
$11.5M Sell
193,655
-26,962
-12% -$1.72M 0.07% 222
2021
Q4
$16M Sell
220,617
-11,273
-5% -$776K 0.09% 193
2021
Q3
$16.2M Sell
231,890
-770
-0.3% -$54.1K 0.1% 183
2021
Q2
$16M Buy
232,660
+27,111
+13% +$1.81M 0.1% 189
2021
Q1
$13.3M Sell
205,549
-6,527
-3% -$421K 0.1% 197
2020
Q4
$12.4M Sell
212,076
-5,740
-3% -$346K 0.09% 208
2020
Q3
$13.8M Buy
217,816
+15,323
+8% +$1.06M 0.11% 150
2020
Q2
$15.6M Buy
202,493
+63,979
+46% +$4.9M 0.15% 122
2020
Q1
$10.4M Sell
138,514
-160,336
-54% -$11.1M 0.18% 106
2019
Q4
$19.4M Sell
298,850
-18,276
-6% -$1.19M 0.14% 132
2019
Q3
$20.1M Sell
317,126
-70,874
-18% -$4.63M 0.19% 117
2019
Q2
$26.2M Sell
388,000
-2,168
-0.6% -$143K 0.23% 108
2019
Q1
$25.4M Sell
390,168
-102,963
-21% -$6.84M 0.23% 110
2018
Q4
$30.8M Buy
493,131
+29,176
+6% +$2.04M 0.27% 89
2018
Q3
$35.8M Sell
463,955
-147,341
-24% -$11.1M 0.38% 57
2018
Q2
$43.3M Sell
611,296
-113,633
-16% -$8.02M 0.38% 54
2018
Q1
$54.7M Sell
724,929
-17,119
-2% -$1.36M 0.42% 51
2017
Q4
$53.2M Buy
742,048
+23,719
+3% +$1.8M 0.37% 57
2017
Q3
$58.2M Buy
718,329
+5,712
+0.8% +$437K 0.45% 50
2017
Q2
$50.4M Sell
712,617
-40,260
-5% -$2.68M 0.4% 48
2017
Q1
$51.1M Sell
752,877
-38,225
-5% -$2.69M 0.41% 48
2016
Q4
$56.7M Buy
791,102
+73,223
+10% +$5.44M 0.5% 45
2016
Q3
$56.8M Sell
717,879
-116,559
-14% -$9.47M 0.57% 39
2016
Q2
$69.6M Sell
834,438
-38,640
-4% -$3.43M 0.61% 37
2016
Q1
$80.2M Buy
873,078
+331
+0% +$29.8K 0.75% 26
2015
Q4
$88.3M Sell
872,747
-16,564
-2% -$1.72M 0.85% 20
2015
Q3
$87.3M Sell
889,311
-19,746
-2% -$2.19M 0.89% 18
2015
Q2
$106M Sell
909,057
-79,592
-8% -$8.7M 1.01% 13
2015
Q1
$97M Sell
988,649
-227,197
-19% -$23.1M 0.88% 15
2014
Q4
$115M Sell
1,215,846
-17,325
-1% -$1.79M 0.95% 14
2014
Q3
$131M Sell
1,233,171
-75,603
-6% -$7.4M 1.1% 11
2014
Q2
$109M Sell
1,308,774
-8,018
-0.6% -$624K 0.88% 17
2014
Q1
$93.3M Sell
1,316,792
-133,806
-9% -$10.5M 0.79% 22
2013
Q4
$109M Buy
1,450,598
+23,587
+2% +$1.64M 0.86% 16
2013
Q3
$89.7M Sell
1,427,011
-98,399
-6% -$5.88M 0.76% 26
2013
Q2
$78.2M Buy
+1,525,410
New +$79.5M 0.64% 34

Other funds holding GILD

British Columbia Investment Management's GILD Position: Q1 2026 in Review

British Columbia Investment Management reduced its Gilead Sciences (GILD) stake by 22% in Q1 2026, selling an estimated $6.89M and leaving 170,998 shares worth $23.8M. The position accounts for 0.14% of the portfolio, ranked #123.

British Columbia Investment Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $131M in Q3 2014. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • British Columbia Investment Management held 170,998 shares of Gilead Sciences worth $23.8M as of Q1 2026.
  • British Columbia Investment Management sold 49,181 Gilead Sciences shares in Q1 2026, an estimated $6.89M.
  • Gilead Sciences made up 0.14% of British Columbia Investment Management's portfolio in Q1 2026, its #123 holding.
  • British Columbia Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's Gilead Sciences position peaked at $131M in Q3 2014.
  • 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.